These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32422307)

  • 1. Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma.
    Bashir AO; El-Mesery ME; Anwer R; Eissa LA
    Life Sci; 2020 Aug; 254():117794. PubMed ID: 32422307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis.
    Ashour AE; Abd-Allah AR; Korashy HM; Attia SM; Alzahrani AZ; Saquib Q; Bakheet SA; Abdel-Hamied HE; Jamal S; Rishi AK
    Mol Cell Biochem; 2014 Apr; 389(1-2):85-98. PubMed ID: 24399465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
    Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
    Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage.
    Zhang R; Wu T; Zheng P; Liu M; Xu G; Xi M; Yu J
    DNA Repair (Amst); 2021 Jul; 103():103117. PubMed ID: 33990030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling.
    Shimia M; Amini M; Ravari AO; Tabnak P; Valizadeh A; Ghaheri M; Yousefi B
    Chem Biol Drug Des; 2024 Aug; 104(2):e14587. PubMed ID: 39175102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms.
    Fatfat M; Fakhoury I; Habli Z; Mismar R; Gali-Muhtasib H
    Life Sci; 2019 Sep; 232():116628. PubMed ID: 31278946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
    El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
    Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
    Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
    Chem Biol Interact; 2018 Jan; 279():84-94. PubMed ID: 29133031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
    Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diosgenin potentiates the anticancer effect of doxorubicin and volasertib via regulating polo-like kinase 1 and triggering apoptosis in hepatocellular carcinoma cells.
    Yousef EH; El-Mesery ME; Habeeb MR; Eissa LA
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4883-4894. PubMed ID: 38165424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Serum microRNA155 and Telomerase Expression in Hepatocellular Carcinoma.
    Ezzat WM; Amr KS; Raouf HA; Elhosary YA; Hegazy AE; Fahim HH; Kamel RR
    Arch Med Res; 2016 Jul; 47(5):349-355. PubMed ID: 27751368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
    Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
    World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of the miR-325-3p/DPAGT1 axis supports HBV-positive HCC chemoresistance.
    Li R; Xu T; Wang H; Wu N; Liu F; Jia X; Mi J; Lv J; Gao H
    Biochem Biophys Res Commun; 2019 Nov; 519(2):358-365. PubMed ID: 31519321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
    Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
    J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoquinone Selectively Induces Hepatocellular Carcinoma Cell Apoptosis in Synergism With Clinical Therapeutics and Dependence of p53 Status.
    Jehan S; Zhong C; Li G; Zulqarnain Bakhtiar S; Li D; Sui G
    Front Pharmacol; 2020; 11():555283. PubMed ID: 33041795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.